Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT von O'Neill, A, Mikesch, K, Fritsch, K, Kasenda, B, Banerjee, L, Burns, F, Zakout, G, Johnston, R, Illerhaus, G, Cwynarski, K

Volltext

Thymic Carcinoma with Overexpression of Mutated KIT and the Response to Imatinib von Mikesch, Kristina, Marx, Alexander, Dirnhofer, Stefan, Ströbel, Philipp, Jakob, Andreas, Hartmann, Martina, Brink, Ingo

Volltext

Evidence for idiotype-directed immunosurveillance is restricted to follicular lymphoma and attributable to somatic hypermutation von Papaioannou, Dimitrios, Strothmeyer, Anna-Maria, Dühren-von Minden, Marcus, Keppler-Hafkemeyer, Andrea, Zirlik, Katja, Mikesch, Kristina, van Bergen, Cornelis A M, Navarrete, Marcelo A, Veelken, Hendrik

Volltext

Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma : Specific immune responses despite profound immunosuppression von BERTINETTI, Cristina, ZIRLIK, Katja, HEINING-MIKESCH, Kristina, IHORST, Gabriele, DIERBACH, Heide, WALLER, Cornelius F, VEELKEN, Hendrik

Volltext

Krampfanfall nach Billroth-II-Operation von Harder, J, Mikesch, K, Mohr, L, Blum, H E

Volltext

Seizures following Billroth II gastrectomy von Harder, J, Mikesch, K, Mohr, L, Blum, H E

Volltext

Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT von O'Neill, A, Mikesch, K, Fritsch, K, Kasenda, B, Banerjee, L, Burns, F, Zakout, G, Johnston, R, Illerhaus, G, Cwynarski, K

Volltext

Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells von Yusenko, Maria V., Trentmann, Amke, Andersson, Mattias K., Ghani, Luca Abdel, Jakobs, Anke, Arteaga Paz, Mari-Francis, Mikesch, Jan-Henrik, Peter von Kries, Jens, Stenman, Göran, Klempnauer, Karl-Heinz

Volltext

SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma von Isfort, Ilka, Cyra, Magdalene, Elges, Sandra, Kailayangiri, Sareetha, Altvater, Bianca, Rossig, Claudia, Steinestel, Konrad, Grünewald, Inga, Huss, Sebastian, Eßeling, Eva, Mikesch, Jan-Henrik, Hafner, Susanne, Simmet, Thomas, Wozniak, Agnieszka, Schöffski, Patrick, Larsson, Olle, Wardelmann, Eva, Trautmann, Marcel, Hartmann, Wolfgang

Volltext

High‐dose melphalan‐based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute m... von Steckel, Nina K., Groth, Christoph, Mikesch, Jan‐Henrik, Trenschel, Rudolf, Ottinger, Hellmut, Kordelas, Lambros, Mueller‐Tidow, Carsten, Schliemann, Christoph, Reicherts, Christian, Albring, Joern C., Silling, Gerda, Schmidt, Eva, Berdel, Wolfgang E., Lenz, Georg, Ditschkowski, Markus, Beelen, Dietrich W., Stelljes, Matthias

Volltext

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia von Angenendt, Linus, Bormann, Eike, Pabst, Caroline, Alla, Vijay, Görlich, Dennis, Braun, Leonie, Dohlich, Kim, Schwöppe, Christian, Bohlander, Stefan K., Arteaga, Maria Francisca, Wethmar, Klaus, Hartmann, Wolfgang, Angenendt, Adrian, Kessler, Torsten, Mesters, Rolf M., Stelljes, Matthias, Rothenberg-Thurley, Maja, Spiekermann, Karsten, Hébert, Josée, Sauvageau, Guy, Valk, Peter J. M., Löwenberg, Bob, Serve, Hubert, Müller-Tidow, Carsten, Lenz, Georg, Wörmann, Bernhard J., Sauerland, M. Christina, Hiddemann, Wolfgang, Berdel, Wolfgang E., Krug, Utz, Metzeler, Klaus H., Mikesch, Jan-Henrik, Herold, Tobias, Schliemann, Christoph

Volltext

Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center von Pohlen, Michele, Marx, Julia, Mellmann, Alexander, Becker, Karsten, Mesters, Rolf M, Mikesch, Jan-Henrik, Schliemann, Christoph, Lenz, Georg, Müller-Tidow, Carsten, Büchner, Thomas, Krug, Utz, Stelljes, Matthias, Karch, Helge, Peters, Georg, Gerth, Hans U, Görlich, Dennis, Berdel, Wolfgang E

Volltext

P478: THE GERMLINE VARIANT GFI1‐36N PROMOTES GENETIC INSTABILITY IN LEUKEMIC CELLS AND OPENS NEW THERAPEUTIC APPROACHES FOR ABOUT 15% OF ALL AML PATIENTS von Vorwerk, J., Frank, D., Sun, K., Neumannn, F., Heuser, M., Kunadt, D., Berdel, W. E., Mikesch, J.‐H., Schliemann, C., Lenz, G., Jayavelu, A. K., Khandanpour, C.

Volltext

Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: A TRAnsition to targeted therapies von Arteaga, M F, Mikesch, J-H, Fung, T-K, So, C W E

Volltext

Aldehyde Dehydrogenase 2 (ALDH2) Expression Predicts a Poor Prognosis in Acute Myeloid Leukemia von Angenendt, Linus, Bormann, Eike, Mikesch, Jan-Henrik, Herold, Tobias, Metzeler, Klaus H., Bohlander, Stefan K., Görlich, Dennis, Arteaga, Maria Francisca, Wörmann, Bernhard J., Lenz, Georg, Hiddemann, Wolfgang, Spiekermann, Karsten, Krug, Utz, Sauerland, Christina, Berdel, Wolfgang E., Schliemann, Christoph

Volltext

Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential von BRANDT, Burkhard, ROETGER, Antje, BIDART, Jean-Michel, PACKEISEN, Jens, SCHIER, Katrin, MIKESCH, Jan-Hendrik, KEMMING, Dirk, BOECKER, Werner, DIHUA YU, BUERGER, Horst

Volltext

Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness von Brandt, Burkhard, Mikesch, Jan-Hendrik, Simon, Ronald, Rötger, Antje, Kemming, Dirk, Schier, Katrin, Sauter, Guido, Bürger, Horst

Volltext